First human trial tests new pill for tough blood cancers
Disease control
Recruiting now
This early-stage study is testing a new oral drug called AC676 in adults with B-cell blood cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early…
Phase: PHASE1 • Sponsor: Accutar Biotechnology Inc • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC